HIF-1α Overexpression and Experimental Murine Atherosclerosis

HIF-1α Overexpression and Experimental Murine Atherosclerosis
复制标题

DOI:
10.1161/atvbaha.108.183319
复制
发表时间:
2009-05-01
影响因子:
8.7
通讯作者:
George, Jacob
George, Jacob
中科院分区:
医学1区
文献类型:
--
作者:
Ben-Shoshan, Jeremy;Afek, Arnon;George, Jacob

文献摘要

被引文献

相似文献

背景:淋巴细胞在动脉粥样硬化的进展中起重要作用。最近,缺氧诱导因子-1 (HIF-1)被发现通过调节T细胞活化和细胞因子的产生来减轻炎症。我们研究了在ApoE敲除小鼠淋巴细胞中过表达HIF-1 α对实验性动脉粥样硬化的影响。方法与结果:将apoe(-/-)小鼠静脉注射空质粒或HIF-1 α P564A (HIF-1 α突变稳定构建体)。HIF-1 α在受体动物的脾脏细胞中有明显的表达。RT-PCR检测HIF-1 α处理小鼠脾细胞中IL-10表达升高,ifn - γ表达降低。注射后一周,抗体阵列分析显示与T辅助1向T辅助2转移的模式一致。在牺牲时,对注射HIF-1 α的小鼠主动脉窦病变的评估显示斑块大小显着减少。注射HIF-1小鼠的CD4+脾源淋巴细胞和主动脉中ifn - γ的表达明显降低。结论- hif -1 α在小鼠淋巴细胞中的表达与ifn - γ表达降低和实验性动脉粥样硬化的衰减有关。(中国生物医学杂志,2009;29:665-670)
Background-Lymphocytes play an important role in the progression of atherosclerosis. Recently, hypoxia inducible factor-1 (HIF-1) was found to attenuate inflammation by regulating T cell activation and cytokine production. We studied the effects of overexpression of HIF-1 alpha in ApoE knockout murine lymphocytes, on experimental atherosclerosis.Methods and Results-ApoE(-/-) mice were submitted to intravenous hydrodynamic injection of empty plasmid or HIF-1 alpha P564A (HIF-1 alpha mutated stabilized construct). Robust expression of HIF-1 alpha was evident in spleen cells of recipient animals. Increased expression of IL-10 as well as decreased expression of IFN-gamma was measured in splenocytes of HIF-1 alpha-treated mice by RT-PCR. One week postinjection, antibody array analysis revealed a pattern consistent with a T helper 1 to T helper 2 shift. On sacrifice, assessment of aortic sinus lesions revealed a significant reduction in plaque size in HIF-1 alpha injected mice. A reduced expression of IFN-gamma was evident in CD4+ spleen-derived lymphocytes and aortas of HIF-1 alpha-injected mice.Conclusions-HIF-1 alpha expression in mouse lymphocytes is associated with a reduced IFN-gamma expression and attenuation of experimental atherosclerosis. (Arterioscler Thromb Vasc Biol. 2009; 29: 665-670.)